Pharmaceutical Executive
April 01, 2012
Issue PDF
0
0
Come Rain or Shine
April 01, 2012
Features
0
0
Throughout her life, HBA Woman of the Year Carolyn Buck-Luce has made progress by recognizing that when one door closes, another one opens.
April 01, 2012
Columns
0
0
What does a Scottish vote for independence mean for Big Pharma investment and healthcare funding and delivery in the UK?
April 01, 2012
Features
0
0
India's most prominent scientist, Dr R.A. Mashelkar, President of the Global Research Alliance, on delivering medicines profitably but cheaply to low income countries.
April 01, 2012
Columns
0
0
Disclosure rules the day, as industry confronts demands to report supply problems, results of clinical trials, and payment to doctors.
April 01, 2012
Features
0
0
This year's Ad Stars embrace creativity through the eyes of the patients. Ben Comer and Jennifer Ringler report.
April 01, 2012
Columns
0
0
While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help.
April 01, 2012
Columns
0
0
Too often in M&A or product-linked carve-outs, executives overlook the complexities of disentangling operations and the effort required for regulatory re-registration and labeling changes.
April 01, 2012
Country Report
0
0
Despite the severe blow to its economy, Ukraine has been recovering at a faster rate than its Western European counterparts
April 01, 2012
Columns
0
0
While what is considered 'traditional' marketing has evolved over the years, it's clear that a digital strategy is an absolute necessity to compete today-not just tomorrow.